Dr G. Lainas was elected for the first time as Junior Deputy of Special Interest Group of Reproductive Endocrinology of ESHRE in 2015 , while he holds the post of Senior Deputy since 2017. This is a unique post of global exposure offered to internationally acclaimed scientists and clinicians, who steer the developments of Reproductive Medicine at an international scale.

See the members of ESHRE SIG Reproductive Endrocrinology

See George Lainas Curriculum Vitae

Dr. G.Lainas has an active part in ESHRE, as he is a member in two guidance groups: a) GDG on Ovarian Stimulation in IVF/ICSI and b) ART Clinical Performance Indicators.

The first one is in charge of the guideline development group of ovarian stimulation. This group consists of 15 members and all of them are researchers with a range of scientific work, professors in major European universities and world-class figures in IVF and reproductive endocrinology.

Continue

The Laboratory director of Eugonia’s Embryology Lab was elected as coordinator in the Special Interest Group of Embryology of ESHRE and will undertake his duties in July of 2019.

His election took place in the business meeting of Embryology SIG, during the annual meeting of ESHRE in Barcelona

See the members of Embryology SIG

See Ioannis Sfontouris Cirriculum Vitae

Ioannis Sfontouris is an Honorary Assistant Professor at the University of Nottingham since 2016 and possesses the post of Senior Deputy in Embryology SIG of ESHRE since 2017.

Eugonia is the first Greek IVF Clinic certified for ISO EN 15224:2012 in the field of health, regarding patient’s safety, treatment effectiveness and quality system improvement.

Eugonia has permanent collaboration with other Universities in Greece and abroad, in order to perform pioneering researches which will improve the clinical outcomes.

These Faculties are: Aristotle University of Thessaloniki, University of Nottingham, University of New South Wales, Barts and the London NHS Trust,

The scientific team of Eugonia has developed an innovative treatment for severe Ovarian Hyperstimulation Syndrome, eliminating the risk of complications (according to 5 published studies of our team). This treatment has been established internationally as the tertiary level for the management of OHSS, and is considered as the only available treatment of the syndrome worldwide. 
See more

88% per blastocyst  transferred, for women below  35 years old
See more

In more detail: in our Unit, initiation of antagonist administration is decided according to individualized criteria and is associated with statistically higher pregnancy rates. 
Our study was published in Human Reproduction, official journal of ESHRE (European Society of Human Reproduction and Embryology).
See the publication

The international scientific organization FACULTY of 1000 MEDICINE, which reviews clinical studies, has positively assessed a published study of our team. 
See more

Our study regarding the best ovarian stimulation protocol, had a special mention by the Editor of the journal Human Reproduction. 
See more

Our team has published two of the largest studies (by number of patients included) in the international bibliography, with regards to the new ovarian stimulation treatment for women with poor response and polycystic ovaries. 
There is detailed report of 2 studies of our team in the journal of Human Reproduction.

The first twins born by a paraplegic man were conceived in our center using sperm taken by electroejaculation.